Skip to main content

Table 4 Comparison between patients regarding stroke treatment and serum levels of biomarkers

From: The role of blood protein biomarkers in acute ischemic stroke prognosis

Stroke treatment

CRP

D-Dimer

MMP-9

S100B

BNP

 

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

a) Medical treatment

62.11 ± 55.22

6.58 ± 11.02

769.71 ± 173.67

93.43 ± 201.47

16.64 ± 19.32

b) Thrombolytic Therapy (rtPA)

69.08 ± 69.81

9.06 ± 17.15

724.85 ± 180.34

120.62 ± 244.18

15.45 ± 19.48

c) Mechanical Thrombectomy

90.25 ± 90.18

4.80 ± 5.50

778.68 ± 156.03

85.91 ± 80.59

20.01 ± 22.27

p value

0.791

0.591

0.225

0.306

0.647

  1. rtPA recombinant tissue plasminogen activator, CRP C-reactive protein, MMP-9 matrix Metalloproteinase 9, S100B serum calcium-binding protein Beta, BNP brain natriuretic peptide